LaGier Adriana J, Yoo Sonia H, Alfonso Eduardo C, Meiners Sally, Fini M Elizabeth
Evelyn F. and William L. McKnight Vision Research Center, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA.
Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1061-71. doi: 10.1167/iovs.06-0772.
Transforming growth factor (TGF)-beta2 is a major epithelial mediator of fibrotic marker expression during corneal repair in mice. Production of TGF-beta2 protein by cultured rabbit corneal epithelial cells is reduced by plating on a basement membrane-like extracellular matrix extract (Matrigel; BD Biosciences, Bedford, MA). The goal of the present study was to understand further the nature of Matrigel regulation.
TGF-beta2 protein, mRNA, and gene transcriptional promotion were characterized in cultured human corneal epithelial cells.
TGF-beta2 production was inhibited by Matrigel at the level of mRNA accumulation and activity of the gene transcriptional promoter. This effect of Matrigel was not explained by (1) growth factor contaminants, as growth-factor reduced Matrigel also inhibited TGF-beta2; (2) independent matrix components, as the pure forms of the major ECM components laminin and collagen IV did not reproduce the effect; or (3) inhibition of a constitutive TGF-beta2 autocrine feedback loop, as addition of exogenous TGF-beta2 increased p-Smad3 and restored TGF-beta2 mRNA levels. In addition, Matrigel's ability to reduce TGF-beta2 was not explained by its geometry, as TGF-beta2 production was not inhibited by plating cells on a synthetic nanofiber matrix with a three-dimensional topography similar to Matrigel. Matrigel caused a reduction of ezrin, a member of the ezrin-radixin-moesin (ERM) family, which plays a role in establishing polarity of epithelial cells in tissues through the Rho signaling pathway.
These findings indicate that Matrigel inhibits TGF-beta2 gene expression and point to a mechanism dependent on Matrigel composition and structure. The capacity of Matrigel to reduce ezrin is consistent with this idea and directs the focus of future studies toward the ERM/Rho pathway.
转化生长因子(TGF)-β2是小鼠角膜修复过程中纤维化标志物表达的主要上皮介质。通过在基底膜样细胞外基质提取物(基质胶;BD生物科学公司,马萨诸塞州贝德福德)上接种培养,兔角膜上皮细胞产生的TGF-β2蛋白减少。本研究的目的是进一步了解基质胶调节的本质。
对培养的人角膜上皮细胞中的TGF-β2蛋白、mRNA和基因转录促进作用进行了表征。
基质胶在mRNA积累水平和基因转录启动子活性方面抑制了TGF-β2的产生。基质胶的这种作用不能用以下因素解释:(1)生长因子污染物,因为生长因子减少的基质胶也抑制TGF-β2;(2)独立的基质成分,因为主要细胞外基质成分层粘连蛋白和IV型胶原的纯形式不能重现这种作用;或(3)对组成型TGF-β2自分泌反馈环的抑制,因为添加外源性TGF-β2会增加磷酸化Smad3并恢复TGF-β2 mRNA水平。此外,基质胶降低TGF-β2的能力不能用其几何形状来解释,因为将细胞接种在具有与基质胶相似的三维拓扑结构的合成纳米纤维基质上时,TGF-β2的产生并未受到抑制。基质胶导致埃兹蛋白减少,埃兹蛋白是埃兹蛋白-根蛋白-膜突蛋白(ERM)家族的成员,通过Rho信号通路在组织中上皮细胞极性的建立中发挥作用。
这些发现表明基质胶抑制TGF-β2基因表达,并指出了一种依赖于基质胶组成和结构的机制。基质胶降低埃兹蛋白的能力与这一观点一致,并将未来研究的重点指向ERM/Rho途径。